Utility of noninvasive regional saturation monitoring using with INVOS500 to predict prognosis in pediatric patients with congenital heart disease

Utility of noninvasive regional saturation monitoring using with INVOS500 to predict prognosis in pediatric patients with congenital heart disease - Noninvasive regional saturation monitoring and congenital heart surgery

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031183

Enrollment

Registered

2018-02-07

Start date

2018-02-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pediatric patients with congenital heart disease and body weight under 10 kg

Exclusion criteria

Exclusion criteria: body weight over 10 kg

Design outcomes

Primary

Measure	Time frame
Poor outcomes including 30-day mortality, duration of ICU stay, duration of respiratory ventilation, administration of renal replacement therapy and ECMO	—

Countries

Japan

Contacts

Public ContactJunichi Saito

Hirosaki University Graduate School of Medicine Department of Anesthesiology

masuika@hirosaki-u.ac.jp0172-39-5113

Outcome results